Gluco-Arc
Unibody Continuous Glucose Monitor
Besides traditional finger pricking, Continuous Glucose Monitoring (CGM) is considered the optimal tool for blood glucose control, offering up to 14 days of continuous monitoring. However, current applicators can be unwieldy and may lead to accidental misfiring and medical waste. When self-administering, users often struggle with aligning the device, maintaining the proper posture, and applying the required force. Gluco-Arc is the most convenient CGM to date with zero assembly in one unibody design. It addresses grip, stability, and safety concerns, allowing users to administer it easily and enjoy a two-week carefree glucose monitoring.
Date of Launch
2024
Development Time
up to 12 Month
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Trade / Industry, Consumers / Users